Australia's largest stock trading and investment forum Australia's #1 stock forum

AVR

Click for more information

8.17%

$9.10 anteris technologies ltd

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-168

First 168 Last

Share
Profile

Follow
AlCp

27,826 Posts.

1794

16/10/19

14:53

Post #: 40911695
Share

Originally posted by myusername69 ↑

It seems quite likely given the rapid acceleration in wages was at the time where the US sales staff rapidly expanded. That department doesn't need to be there in its entirety since the product is licensed (and therefore marketing and sales costs) will be incurred by LMAT who have plenty of money (and the network of established relationships with centres) to do it.

Where investors should be focussed is the the reduction in staff costs (much larger than marketing spend historically) and see how much of that follows into R&D spend. That will drive the cashflow situation. It's a tough balancing act, because at the same time they have to continue to invest in TAVR as a platform as that's the company's focus. If all the majority of savings are driven into R&D - the company would benefit from a complete rebrand as they will require further capital to drive this initiative at some point, unless they get into a partnership earlier than later.

Expand

They did explain the employee cost did increase by 37% due to this reallocation to the US in their latest financial (hence this will explain an average salary from $150K in the previous financial year to $200K) but still, double Australia's average salary......

AHZ Price at posting: 6.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

AR3

Overland drilling proves promising for Australian Rare Earths' uranium hopes

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CPV

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

There are more pages in this discussion • 122 more messages in this thread...

First 168 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $9.10		Change -0.810(8.17%)		Mkt cap ! $192.3M

Open	High	Low	Value	Volume
$9.50	$9.77	$9.01	$212.2K	22.63K

Buyers (Bids)

No.	Vol.	Price($)
1	298	$9.01

Sellers (Offers)

Price($)	Vol.	No.
$9.85	1000	1

View Market Depth

No.	Vol.	Price($)
1	298	9.010
1	1000	9.000
1	200	8.700
1	200	8.500
2	200	8.000

Price($)	Vol.	No.
9.850	1000	1
9.910	231	2
10.000	10250	2
10.200	545	1
10.500	10000	1

Last trade - 16.10pm 13/11/2024 (20 minute delay)

AVR (ASX) Chart